194 related articles for article (PubMed ID: 9020771)
21. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
22. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
23. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
24. Achieving antisense inhibition by oligodeoxynucleotides containing N(7)-modified 2'-deoxyguanosine using tumor necrosis factor receptor type 1.
Ojwang JO; Rando RF
Methods; 1999 Jul; 18(3):244-51. PubMed ID: 10454982
[TBL] [Abstract][Full Text] [Related]
25. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
[TBL] [Abstract][Full Text] [Related]
26. An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers.
Bonham MA; Brown S; Boyd AL; Brown PH; Bruckenstein DA; Hanvey JC; Thomson SA; Pipe A; Hassman F; Bisi JE
Nucleic Acids Res; 1995 Apr; 23(7):1197-203. PubMed ID: 7537874
[TBL] [Abstract][Full Text] [Related]
27. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
28. 2',5'-linked oligo-3'-deoxyribonucleoside phosphorothioate chimeras: thermal stability and antisense inhibition of gene expression.
Bhan P; Bhan A; Hong M; Hartwell JG; Saunders JM; Hoke GD
Nucleic Acids Res; 1997 Aug; 25(16):3310-7. PubMed ID: 9241246
[TBL] [Abstract][Full Text] [Related]
29. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
[TBL] [Abstract][Full Text] [Related]
31. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.
Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F
Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
33. Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.
Kubo T; Bakalova R; Zhelev Z; Ohba H; Fujii M
Nucleic Acids Symp Ser (Oxf); 2005; (49):337-8. PubMed ID: 17150771
[TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
35. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
Flanagan WM; Su LL; Wagner RW
Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
[TBL] [Abstract][Full Text] [Related]
36. PAcM-AN: poly (N-acryloylmorpholine)-conjugated antisense oligonucleotides.
Bonora GM; De Franco AM; Rossin R; Veronese FM; Ferruti P; Plyasunova O; Vorobjev PE; Pyshnyi DV; Komarova NI; Zarytova VF
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1281-8. PubMed ID: 11097058
[TBL] [Abstract][Full Text] [Related]
37. Oligodeoxynucleotide analogs as informational drugs to regulate translation.
Ghosh M; Ghosh K; Cohen JS
Nucleic Acids Symp Ser; 1991; (24):139-42. PubMed ID: 1668685
[TBL] [Abstract][Full Text] [Related]
38. Chimeric oligodeoxynucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity.
Giles RV; Spiller DG; Tidd DM
Anticancer Drug Des; 1993 Feb; 8(1):33-51. PubMed ID: 8386514
[TBL] [Abstract][Full Text] [Related]
39. The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides.
ten Asbroek AL; van Groenigen M; Nooij M; Baas F
Eur J Biochem; 2002 Jan; 269(2):583-92. PubMed ID: 11856317
[TBL] [Abstract][Full Text] [Related]
40. 3'-5' L-capped-antisense oligodeoxynucleotides targeted at the SV40 T-antigen gene: pharmacological and biological properties.
Pettenazzo E; Maschera B; Bevilacqua F; Capobianco ML; Palù G
New Microbiol; 1996 Oct; 19(4):273-84. PubMed ID: 8914127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
